| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |